Healthcare Sales & Marketing Network News: Sublinox

Searching News Database: Sublinox

HSMN NewsFeed - 7 Apr 2014
Meda and Valeant Terminates Joint Ventures
Biopharmaceuticals

HSMN NewsFeed - 16 Mar 2009
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Dec 2008
Abstral receives marketing approval in Germany
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Aug 2008
Meda Enters into Joint Venture with Valeant
Biopharmaceuticals

HSMN NewsFeed - 7 Aug 2008
Valeant Announces Agreement to Enter into Joint Venture with Meda
Biopharmaceuticals

HSMN NewsFeed - 31 Jul 2008
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Jun 2008
Orexo Strengthens the Executive Management Group
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Apr 2008
Meda and Orexo in a Potential Billion SEK Deal
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 1 Oct 2007
Orexo Shows Positive Results in Completed Comparative Phase III Profile Study of the Sublinox(TM) Sleep Aid Involving Insomnia Patients
Biopharmaceuticals

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.